🔎 Trials Near Me

Pradžia › Geografinė atrofija › Nevada

Geografinė atrofija klinikiniai tyrimai Nevada

8 tyrimai dėl Geografinė atrofija ieško dalyvių vietose Nevada.

Miestai Nevada

Oficialus tyrimo tekstas (anglų kalba)

A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)

  • Sierra Eye Associates, Reno
Renkami dalyviai2/3 fazė
Amžius 60 ir vyresni · Visoms lytims · Atnaujinta 2026-09-30 · NCT06635148

A Phase 1/2 Study of the Safety and Efficacy of BRX011 Oral Administration Once Daily in Subjects With Geographic Atrophy Secondary to Age-Related Macular Degeneration

  • Sierra Eye Associates, Reno
Renkami dalyviai1/2 fazė
Amžius 55 ir vyresni · Visoms lytims · Atnaujinta 2026-09-23 · NCT07029945

A Safety and Efficacy Study of a One-time Intravitreal Injection of SAR446597 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration

  • Sierra Eye Associates- Site Number : 8400021, Reno
Renkami dalyviai1/2 fazė
Amžius 60 ir vyresni · Visoms lytims · Atnaujinta 2026-09-22 · NCT07215234

Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD

  • Sierra Eye Associates, Reno
Renkami dalyviai2 fazė
Amžius 55 ir vyresni · Visoms lytims · Atnaujinta 2026-09-10 · NCT06659445

A Non-Interventional Study Observing Short-Term Progression in Geographic Atrophy (GA)

  • Sierra Eye Associates, Reno
Renkami dalyviaiStebimasis tyrimas
Amžius 55 ir vyresni · Visoms lytims · Atnaujinta 2026-09-03 · NCT07144137

Microcurrent Stimulation Therapy for Intermediate to Advanced Nonexudative Age-related Macular Degeneration

  • Sierra Eye Associates, Reno
Renkami dalyviai
Amžius 60 ir vyresni · Visoms lytims · Atnaujinta 2026-08-26 · NCT06662162

Study to Assess the Adverse Events and How Intravitreal ABBV-6628 Moves Through the Body of Adult Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration

  • Sierra Eye Associates /ID# 262142, Reno
Renkami dalyviai1/2 fazė
Amžius 50 ir vyresni · Visoms lytims · Atnaujinta 2026-07-13 · NCT07160179

Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.